| Secondary |
| Product Used For Unknown Indication |
31.4% |
| Pain |
16.0% |
| Osteitis |
12.1% |
| Drug Use For Unknown Indication |
9.7% |
| Anaesthesia |
3.6% |
| Analgesic Therapy |
3.6% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.4% |
| Headache |
2.4% |
| Hiv Infection |
2.4% |
| Insomnia |
2.4% |
| Spondylitis |
2.4% |
| Induction Of Anaesthesia |
1.8% |
| Oedema Peripheral |
1.5% |
| Osteomyelitis Chronic |
1.5% |
| Immunosuppressant Drug Therapy |
1.2% |
| Ischaemia |
1.2% |
| Postoperative Analgesia |
1.2% |
| Ureteric Operation |
1.2% |
| Analgesia |
0.9% |
| General Anaesthesia |
0.9% |
|
| Withdrawal Syndrome |
12.5% |
| Overdose |
10.4% |
| Pain |
10.4% |
| Visual Acuity Reduced |
6.3% |
| Anaphylactic Shock |
4.2% |
| Basedow's Disease |
4.2% |
| Cardio-respiratory Arrest |
4.2% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.2% |
| Eosinophilia |
4.2% |
| General Physical Health Deterioration |
4.2% |
| Human Herpes Virus 6 Serology Positive |
4.2% |
| Hypotension |
4.2% |
| International Normalised Ratio Increased |
4.2% |
| Neutropenia |
4.2% |
| Pancreatitis Haemorrhagic |
4.2% |
| Rash Vesicular |
4.2% |
| Transaminases Increased |
4.2% |
| Acute Generalised Exanthematous Pustulosis |
2.1% |
| Agranulocytosis |
2.1% |
| Atrial Fibrillation |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.6% |
| Prophylaxis |
11.1% |
| Drug Use For Unknown Indication |
6.3% |
| Hypertension |
5.5% |
| Analgesic Therapy |
4.2% |
| Sedation |
3.5% |
| Depression |
3.4% |
| Infection |
3.4% |
| Pain |
3.4% |
| Anaemia |
2.6% |
| Medical Diet |
2.6% |
| Peritonitis |
2.6% |
| Rheumatoid Arthritis |
2.1% |
| Acute Myeloid Leukaemia |
1.9% |
| Septic Shock |
1.8% |
| Bronchial Disorder |
1.6% |
| Hypovolaemia |
1.6% |
| Pulmonary Embolism |
1.4% |
| Acquired Immunodeficiency Syndrome |
1.2% |
| Analgesic Effect |
1.2% |
|
| Myositis |
11.8% |
| White Blood Cell Count Decreased |
8.2% |
| General Physical Health Deterioration |
5.9% |
| Hallucination, Visual |
5.9% |
| Neuroendocrine Carcinoma Of The Skin |
5.9% |
| Pharmaceutical Product Complaint |
5.9% |
| Somnambulism |
5.9% |
| Jaundice |
4.7% |
| Sepsis |
4.7% |
| Swollen Tongue |
4.7% |
| Tremor |
4.7% |
| Angioedema |
3.5% |
| Bone Pain |
3.5% |
| Cytomegalovirus Infection |
3.5% |
| Drug Interaction |
3.5% |
| Malignant Melanoma |
3.5% |
| Peripheral Ischaemia |
3.5% |
| Salivary Gland Enlargement |
3.5% |
| Serotonin Syndrome |
3.5% |
| Treatment Noncompliance |
3.5% |
|
